Skip to main content

Table 2 Patient characteristics of the biomarker validation HF patient cohort

From: Using matrix assisted laser desorption ionisation mass spectrometry (MALDI-MS) profiling in order to predict clinical outcomes of patients with heart failure

Characteristics

HF hospitalisation or death (n = 58)

No event (n = 42)

p value

Age (years)

69.52 ± 12.15

68.86 ± 11.95

0.696

Male sex, n (%)

29 (50.0)

20 (47.6)

0.814

BMI (kg/m2)

27.76 ± 6.20

29.27 ± 5.85

0.125

NYHA class III/IV, n (%)

36 (65.5)

27 (64.3)

0.905

Systolic blood pressure (mmHg)

125.10 ± 25.20

123.52 ± 17.07

0.936

Diastolic blood pressure (mmHg)

72.00 ± 14.41

75.50 ± 11.48

0.054

Heart rate (bpm)

82.53 ± 22.37

83.55 ± 24.52

0.975

BNP (pg/mL)

467.45 ± 433.66

288.49 ± 390.02

0.004

Serum creatinine (µmol/L)

123.72 ± 47.06

101.32 ± 46.09

0.004

eGFR (mL/min−1)

53.74 ± 20.03

67.63 ± 27.72

0.013

Primary aetiology

   

 Ischaemic heart disease

27 (47.4)

15 (36.6)

0.287

 Non ischaemic heart disease

30 (52.6)

26 (63.4)

0.287

  1. Italic values indicate significance of p value (p < 0.05)
  2. BMI body mass index, BNP brain natriuretic peptide, eGFR estimated glomerular filtration rate, NYHA New York Heart Association